21-HYDROXYLASE DEFICIENCY

This adverse event was reported 10 times

21-HYDROXYLASE DEFICIENCY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETRAVIRINE 5 0.0011
1 TENOFOVIR DISOPROXIL FUMARATE TABLETS 3 0.0003
2 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 1 0.0001
3 CANDESARTAN CILEXETIL 1 0.0000
4 OLANZAPINE PAMOATE 1 0.0000
5 AZITHROMYCIN DIHYDRATE 1 0.0000
6 OLANZAPINE 1 0.0000
7 EZETIMIBE 1 0.0000
8 ROSUVASTATIN 1 0.0000
9 FENTANYL 1 0.0000
See all drugs enriched for association with 21-HYDROXYLASE DEFICIENCY